Inherited and acquired risk factors and their combined effects in pediatric stroke

被引:57
作者
Barreirinho, S
Ferro, A
Santos, M
Costa, E
Pinto-Basto, J
Sousa, A
Sequeiros, J
Maciel, P
Barbot, C
Barbot, J
机构
[1] Hosp Criancas Maria Pia, Serv Hematol, P-4050111 Oporto, Portugal
[2] Hosp Criancas Maria Pia, Serv Neuropediat, P-4050111 Oporto, Portugal
[3] Univ Porto, Inst Biol Mol & Celular, UnIGENe, P-4100 Oporto, Portugal
[4] Univ Porto, ICBAS, Dept Estudos Populacoes, P-4100 Oporto, Portugal
关键词
D O I
10.1016/S0887-8994(02)00506-4
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
The aim of this study was to identify hereditary and acquired risk-factors as they are related to the occurrence of stroke in children. We identified 21 children with stroke. A search of the Factor V Leiden mutation, the Factor II G20210A variant, and the thermolabile variant of methylene-tetrahydrofolate reductase was performed in patients and in a control group (n = 115). We identified risk factors of acquired and/or hereditary nature for stroke in 19 of 21 children. Eleven children had three or more risk factors, seven had two risk factors, and one child had only one risk factor. We found three carriers (14.3%) of the Factor V Leiden mutation, two carriers (9.5%) of the Factor II G20210A variant, eleven (52.4%) thermolabile variant of methylenetetrahydrofolate reductase heterozygote carriers, and one (4.8%) homozygotes for this variant. Frequencies of the Factor V Leiden mutation and the Factor II variant were higher in patients than in controls, suggesting that these variants are associated with an increased risk of stroke in childhood. Homozygosity for the thermolabile variant of methylenetetrahydrofolate reductase was equally frequent amongst patients and controls. Our study confirms that stroke in children is commonly associated with a combination of multiple risk factors, both genetic and acquired, and that the Factor V Leiden mutation and the Factor II G20210A variant are predisposing factors for this situation. (C) 2003 by Elsevier Inc. All rights reserved.
引用
收藏
页码:134 / 138
页数:5
相关论文
共 15 条
  • [1] Andrew M, 2000, THROMBOEMBOLIC COMPL, P201
  • [2] Andrews PI, 1999, GENETICS OF CEREBROVASCULAR DISEASE, P261
  • [3] BALASA V, 1998, J PEDIAT HEMATOL ONC, V20, P370
  • [4] DEVEBER G, 1999, PEDIAT NEUROLOGY PRI, P1099
  • [5] Development of an internal restriction control in the PCR detection of the prothrombin 20210A mutation
    Dubreuil, RM
    Lastrucci, RMD
    Dawson, DA
    Münster, M
    [J]. CLINICAL AND LABORATORY HAEMATOLOGY, 1999, 21 (04): : 281 - 283
  • [6] STROKE IN CHILDREN - CLINICAL CHARACTERISTICS AND PROGNOSIS
    EEGOLOFSSON, O
    RINGHEIM, Y
    [J]. ACTA PAEDIATRICA SCANDINAVICA, 1983, 72 (03): : 391 - 395
  • [7] CEREBROVASCULAR-DISEASE IN CHILDREN UNDER 16 YEARS OF AGE IN THE CITY OF DIJON, FRANCE - A STUDY OF INCIDENCE AND CLINICAL-FEATURES FROM 1985 TO 1993
    GIROUD, M
    LEMESLE, M
    GOUYON, JB
    NIVELON, JL
    MILAN, C
    DUMAS, R
    [J]. JOURNAL OF CLINICAL EPIDEMIOLOGY, 1995, 48 (11) : 1343 - 1348
  • [8] Congenital thrombophilia and thrombosis: a study in a single centre
    Lawson, SE
    Butler, D
    Enayat, MS
    Williams, MD
    [J]. ARCHIVES OF DISEASE IN CHILDHOOD, 1999, 81 (02) : 176 - 178
  • [9] Ischemic cerebrovascular disease in children: Retrospective study of 35 patients
    Mancini, J
    Girard, N
    Chabrol, B
    Lamoureux, S
    Livet, MO
    Thuret, I
    Pinsard, N
    [J]. JOURNAL OF CHILD NEUROLOGY, 1997, 12 (03) : 193 - 199
  • [10] Lipoprotein (a) and genetic polymorphisms of clotting factor V, prothrombin, and methylenetetrahydrofolate reductase are risk factors of spontaneous ischemic stroke in childhood
    Nowak-Göttl, U
    Sträter, R
    Heinecke, A
    Junker, R
    Koch, HG
    Schuierer, G
    von Eckardstein, A
    [J]. BLOOD, 1999, 94 (11) : 3678 - 3682